Page 12 - Eyepoint Pharmaceuticals News Today : Breaking News, Live Updates & Top Stories | Vimarsana

For Retina Specialists, 2024 Is a Time to Try New Tools

This is a year for ophthalmologists to get acclimated with three blockbuster retina drugs approved in 2023, get reacclimated with a returning implant, and to brace for 2025 and beyond.

United statesWest virginiaIveric bioAbbvie allerganGenentech rochePegcetacoplan syfovreReginal sandersSamsung bioepisDavid boyerLos angelesRetina societyJanssen pharmaceuticalsAmerican society of retina specialistDrug administrationEyepoint pharmaceuticalsRegeneron pharmaceuticals

A Review Of The Developmental Landscape Of Long-Acting Anti-VEGF Therapies In Wet-AMD

A Review Of The Developmental Landscape Of Long-Acting Anti-VEGF Therapies In Wet-AMD
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

United statesEyepoint pharmaceuticalsMolecular therapeutics

EyePoint Pharmaceuticals: Innovating Eye Treatment, Yet A Hold At This Time (EYPT)

EyePoint Pharmaceuticals: Innovating Eye Treatment, Yet A Hold At This Time (EYPT)
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

United statesZorica nastasicIcon bioscience incEyepoint pharmaceuticalsEyepoint pharmaceuticals incSivida corpPoint pharmaceuticalsIcon bioscienceEyepoint investor presentation januaryAge related macular degenerationNon proliferative diabetic retinopathyDiabetic macular edemaGeographic atrophySeeking alpha

The 3 Most Promising Stocks to Invest in Before They Take Off

EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesMacau generalHong kongChristina tartagliastern irdirectEyepoint pharmaceuticalsEyepoint pharmaceuticals nasdaqEyepoint pharmaceuticals incEquinox sciencesCompensation committeeBetta pharmaceuticalsPoint pharmaceuticalsTerm incentive planEyepoint pharmaceuticalChristina tartagliasternAmy phillipsgreen room communicationsdirect